T2-FLAIR mismatch sign was reported as the novel imaging biomarker for astrocytoma, IDH-mutant and 1p/19q non-codeletion [7], and several studies have validated the reliability of this sign [14]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).